TSX closed
Loading marketsโ€ฆ

Advertisement

Stocks

Knight Therapeutics Inc. GUD Earnings Miss Estimates by 188.0%

By Wealth Awesome -

Follow live quotes and coverage.

Stocks & ETFs:GUD.TO

Get GUD alerts:

Photos provided by Pexels

Knight Therapeutics faces a significant earnings miss, raising questions about future performance.

Recent earnings trend

Advertisement

Knight Therapeutics Inc.

GUD.TO

Full stock page โ†’

GUD.TO

Knight Therapeutics Inc.

Source:WealthAwesomeWealthAwesome
โ†‘ $3.90 (63.52%)
120 day period
$6.14$8.11$10.07Mar 16Jun 10Sep 3

Market cap

$949.90M

P/E

64.5x

52W high

$10.17

52W low

$5.66

1W change

+4.69%

Beta

0.05

Analyst Price Targets

Based on analyst covering GUD

๐Ÿ“ˆ

Wall Street analysts forecast GUD stock price to rise 11.4% over the next 12 months.

Consensus

Moderately Bullish

Based on avg. target vs last close (formal rating unavailable for Canadian listings)

Avg. Target

C$11.19

+11.4% Upside

Current Price

C$10.04

Last close

Compare analyst targets across the TSX & TSXV โ†’

Analyst ratings and price targets are updated periodically. Not financial advice.

Wealth Awesome Price Forecast

WA Model

Statistical 90-day price range based on GUD's historical volatility

HistoricalForecast68%95%
C$7.16C$9.25C$11.34C$13.43C$15.52C$17.60TodayApr 28Jul 2Sep 3Oct 16Nov 29Jan 11

30-Day Vol

33.5%

Annualized

90-Day Vol

32.8%

Annualized

Trend (90d)

+36.7%

Annualized drift

90d Mean

C$11.45

Expected price

HorizonExpected68% Range (1ฯƒ)
30 trading daysC$10.49C$9.34 โ€“ C$11.78
60 trading daysC$10.96C$9.30 โ€“ C$12.91
90 trading daysC$11.45C$9.37 โ€“ C$13.99

Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ยฑ1ฯƒ, 95% band = ยฑ2ฯƒ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.

Advertisement

Analyst coverage: 1 analyst(s) cover this name; upcoming EPS consensus is available.

Beat estimates in 2 of the last 4 comparable quarter(s).

Fiscal periodReport dateActual EPSEstimateSurprise
2026-06-302026-08-06-0.02640.0300-188.0%
2026-03-312026-05-060.13890.0100+1289.0%
2025-12-312026-03-190.10000.0100+900.0%
2025-09-302025-11-06-0.01000.0200-150.0%
2025-06-302025-08-07-0.09000.0200-550.0%
2025-03-312025-05-080.0300-0.0100+400.0%
-0.09000.02440.1389 24-0924-1225-0325-0625-0925-1226-0326-06 Estimate Actual (โ‰ฅ0) Actual (<0) Wealth Awesome

Advertisement

Knight Therapeutics Inc. (TSX: GUD) reported its Q2 2026 earnings on August 6, 2026, and the results were disappointing, with an earnings per share (EPS) of -0.0264, missing the consensus estimate of 0.03 by a staggering 188.0%. This marks a notable deviation in performance, especially following two consecutive quarters of positive surprises.

Investor takeaway: The substantial earnings miss could impact investor sentiment and raise concerns over Knight's operational efficiency and future growth prospects. Investors should keep an eye on upcoming analyst revisions and market responses as the company navigates this setback.

EPS Miss of 188% Raises Red Flags

Knight's EPS of -0.0264 starkly contrasts with the expected 0.03, highlighting operational difficulties and potential market challenges ahead.

Bull case

Knight has shown it can bounce back, with two of the last four quarters delivering significant positive surprises. The company is focusing on strategic acquisitions and licensing, which could strengthen its product lineup and boost future revenue growth.

Bear case

The recent earnings miss raises concerns about the company's operational challenges and market positioning. With a low profit margin of 2.72% and a high P/E ratio of 162.67, there are signs of overvaluation. Continued earnings misses could lead to a decline in investor confidence.

Advertisement

Wealth Awesome
Written by

Wealth Awesome

Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.

View Full Profile โ†’

โœ… Reviewed by Certified Financial Professionals

This content has been reviewed by CFAยฎ charterholders and Certified Financial Planners (CFPยฎ) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.

Why these credentials matter: CFAยฎ charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFPยฎ professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.

๐Ÿ“Š Data AccuracyVerified sources
๐Ÿ‡จ๐Ÿ‡ฆ Canadian FocusLocal expertise
๐Ÿ” Fact-CheckedEditorial review

โš ๏ธ Professional Disclaimer

This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.

Published: August 10, 2026
Last Updated: August 10, 2026
PARTNER SPOTLIGHT

Blue Cross Lifeยฎ Term Life Insurance

Affordable term life coverage in Canada โ€” get a free quote in seconds, no credit card required.

  • โœ“Coverage from $100,000 to $5 million, terms of 10โ€“30 years
  • โœ“10% off first-year premiums when couples apply together
  • โœ“Fully digital application โ€” many qualify without a medical exam

Sponsored links

Advertisement